IP Library Granted Patent US 7,949,402
Granted Patent B2
US 7,949,402 · App. 11/643,462 · Granted May 24, 2011

Neuro-stimulation and ablation system

Assignee: Neuropoint Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,949,402
App. No.
11/643,462
Granted
May 24, 2011
Kind
B2
Abstract

The invention provides a system for treating chronic pain including a lead configured and adapted to be percutaneously implanted into an epidural space of a spinal cord, a stimulation generator that delivers electrical stimulation to the spinal cord through the lead to precisely locate the treatment area, and an ablation generator that delivers ablation energy to the treatment area through the same lead to inhibit the chronic pain. The invention also provides a method for treating chronic pain, including providing a lead, inserting the lead percutaneously into the epidural space, locating the treatment area by probing the epidural space while the lead sends electrical stimulation signals, and then ablating the treatment area.

Claims (11)

1. A method for treating chronic pain comprising:

a. providing an implantable lead having an electrode configured to deliver electrical stimulation and ablation energy to a treatment location of a spinal cord of a patient;

b. inserting the lead percutaneously into an epidural space of the spinal cord of the patient;

c. locating the treatment location on the spinal cord by:

i. sending electrical stimulation through the lead to the electrode; and

ii. probing with the lead in the epidural space until the electrode reaches the treatment location on the patient's spinal cord where the patient experiences a physiological reaction from the electrical stimulation indicative of the electrode contacting the treatment location; and

d. delivering ablation energy to the electrode to ablate nerve tissue proximate the treatment location.

2. The method recited in claim 1 , wherein the step of delivering ablation energy includes controlling ablation temperature by receiving feedback from a temperature sensor.

3. The method recited in claim 1 , wherein the lead has a plurality of electrodes, and wherein the locating step includes cycling through the plurality of electrodes with stimulation signals.

4. The method recited in claim 1 , further comprising the step of switching the lead from a stimulation mode, in which electrical stimulation is sent from a stimulation generator to the electrode, to an ablation mode, in which ablation energy is sent from an ablation generator to the electrode.

5. The method recited in claim 4 , further comprising the step of controlling the output levels for the stimulation and ablation generators using a processor.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2007
From: OSCOR INC.
To: NEUROPOINT MEDICAL, INC.
Reel/Frame 019424/0158 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2007
From: OSYPKA, THOMAS P.
To: OSCOR INC.
Reel/Frame 019306/0409 →
Continuity (2)
Provisional Application 60754051 · Dec 27, 2005
Related Publication 20070219547A1 · Sep 20, 2007